Tech Company Financing Transactions
Janus Biotherapeutics Funding Round
Private investors invested in a $1.1 million funding round for Janus Biotherapeutics. This VC investment round was announced on 8/19/2011.
Transaction Overview
Company Name
Announced On
8/19/2011
Transaction Type
Venture Equity
Amount
$1,100,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
65 William St. 200
Wellesley, MA 02481
USA
Wellesley, MA 02481
USA
Phone
Website
Email Address
Not Recorded
Overview
Janus Biotherapeutics Inc is a project-oriented, biopharmaceutical company focused on progressing a series of small molecule leads for the treatment of autoimmune diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Joseph Baron
Chief Scientific Officer
Grayson Lipford
Vice President
Charlie Zepp
Browse more venture capital transactions:
Prev: 8/19/2011: VisiQuate venture capital transaction
Next: 8/21/2011: Diagnostic Innovations venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs